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PathogenesisNipah virus (NiV) is a highly pathogenic paramyxovirus which causes fatal encephalitis in up to 75% of
infected humans. Endothelial cells and neurons are important cellular targets in the pathogenesis of this
disease. In this study, viral replication and the innate immune responses to NiV in these cell types were
measured. NiV infected endothelial cells generated a functionally robust IFN-β response, which correlated
with localization of the NiV W protein to the cytoplasm. There was no antiviral response detected in infected
neuronal cells. NiV infection of endothelial cells induced a signiﬁcant increase in secreted inﬂammatory
chemokines, which corresponded with the increased ability of infected cell supernatants to induce monocyte
and T-lymphocyte chemotaxis. These results suggest that pro-inﬂammatory chemokines produced by NiV
infected primary endothelial cells in vitro is consistent with the prominent vasculitis observed in infections,
and provide initial molecular insights into the pathogenesis of NiV in physiologically relevant cells types.rt are those of the authors and
ters for Disease Control and
C-22, Atlanta, GA 30333, USA.
Inc.Published by Elsevier Inc.Introduction
Nipah virus (NiV) is a highly pathogenic member of the family
Paramyxoviridae, in the subfamily Paramyxovirinae, in which it along
with Hendra virus makes up the genus Henipavirus (Mayo, 2002). The
ability to generate multiple proteins from a single phosphoprotein (P)
gene by mRNA editing, and/or use of alternative open reading frames
is common among paramyxoviruses (Curran and Kolakofsky, 1990;
Giorgi et al., 1983; Kolakofsky et al., 2005; Liston and Briedis, 1995).
These accessory proteins typically have the ability to antagonize the
host's innate immune response (Gotoh et al., 2002; Horvath, 2004).
Expression of the NiV C, V, and W proteins from plasmid DNA
indicated their varying abilities to antagonize the innate antiviral
response in avian and human cell lines. The NiV C, V, and W proteins
were able to rescue the replication of an interferon (IFN) sensitive
Newcastle Disease virus (Park et al., 2003). The N-terminal regionshared by the NiV P, V, and W proteins binds to signal transduction
activator of transcription (STAT)-1, thus preventing its activation by
phosphorylation (Rodriguez et al., 2004, 2002; Shaw et al., 2004). The
nuclear localization of the NiV W protein enhanced its ability to
antagonize the activation of interferon regulatory factor (IRF) 3 (Shaw
et al., 2005). Characterization of these proteins in NiV infected cells
showed that the phosphoprotein (P) gene mRNA of NiV is edited at a
high frequency to yield mRNAs coding for the NiV V and W proteins,
and that an alternative reading frame in the P gene is utilized to
generate the C protein (Kulkarni et al., 2009; Lo et al., 2009). NiV C and
V were localized to the cell cytoplasm, while NiV W was detected in
the nucleus, and all of the proteins were detected in preparations of
puriﬁed virions (Lo et al., 2009). The interaction between plasmid-
expressed NiVW and karyopherinα3/4 (KPNA3/4) was also detected
in NiV infected cells (Lo et al., 2009; Shaw et al., 2005). More recently,
a reverse genetic study indicated a crucial role of the NiV C protein in
viral replication, and showed that phosphorylated STAT-1 was
precluded from translocating into the nuclei of wild-type NiV infected
Vero E6 cells, while a STAT-1 binding mutant virus allowed for its
nuclear translocation (Ciancanelli et al., 2009). The results of these
studies lead to the question as to whether NiV infection of
physiologically relevant target cells produces similar results as those
seen in the standard cell lines used for viral propagation.
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systemic vasculitis and necrosis particularly in the central nervous
system (CNS). Extensive infection of neurons, endothelial cells, and
smooth muscle cells of blood vessels is characteristic of human NiV
infections (Wong et al., 2002). The molecular basis of NiV pathogen-
esis is still unclear. The inﬂammatory cellular inﬁltrate found in the
central nervous system (CNS) during NiV encephalitis includes
neutrophils, macrophages, lymphocytes, and reactive microglia
(Wong et al., 2002). The recruitment of these cells indicates the
possible action of small molecule messengers and chemoattractants
known as cytokines and chemokines. Some inﬂammatory cytokines
found in infectious CNS pathology include TNFα and IL-6, while some
chemokines include IL-8 (CXCL8), RANTES (CCL5), MIP-1α (CCL3),
MCP-1 (CCL2), and IP-10 (CXCL10) (Glabinski and Ransohoff, 1999).
The cellular sources of these secreted cytokines are varied, as cells of
the CNS as well as the inﬂammatory inﬁltrate have the ability to
produce and secrete these molecules (Grifﬁn, 1997; Owens et al.,
2005). These cytokines and chemokines are also produced in response
to pulmonary inﬂammation due to infection with mycobacterium and
respiratory syncytial virus (RSV) (Kunkel et al., 2002; Pace et al., 1999;
Penido et al., 2003). In order to address the physiological relevance of
previous studies performed in Vero cells, we characterized and
compared the growth characteristics of NiV in several primary human
endothelial cells and a human neuroblastoma cell line. Our ﬁndings
indicate a signiﬁcant difference in viral replication rate between
neurons and endothelial cells. This difference corresponded to the
ability of endothelial cells to generate an IFN-β response, which
correlated with a differential subcellular localization of NiV W
between endothelial cells and neurons. We also demonstrated a
signiﬁcant increase of inﬂammatory chemokines present in super-
natants of NiV infected cells, and showed that increases in these
chemokines correlated with increased induction of functional mono-
cyte and T-lymphocyte chemotaxis.
Results
The rate of NiV replication is signiﬁcantly higher in neuronal cells than in
endothelial cells
In order to measure and compare the infectivity of human
endothelial and neuronal cells, a chemiluminescent immunolabeling
assay was performed in which levels of NiV nucleoprotein (N) served
as an indicator of viral replication (Aljofan et al., 2008). SigniﬁcantFig. 1. Levels of NiV antigen produced by neuronal cells are greater than those produced
by endothelial cells. In this immunolabeling assay, endothelial and neuronal cells were
infected for 16 h, then ﬁxed, washed, and incubated with rabbit anti-NiV N antibodies.
A mouse anti-rabbit IgG antibody conjugated with horseradish peroxidase was used as
a means to measure relative levels of NiV antigen. CTL indicates uninfected controls for
each respective cell type. ** (Pb0.001) (two-tailed Student's t-test with Welch's
modiﬁcation) Compared to levels of chemiluminescence detected from respective
mock-infected endothelial/neuronal cell types. Error bars indicate one standard
deviation of the mean of 5 replicates.levels of NiV antigen could not be detected in the EA926.hy HUVEC-
A549 fusion hybrid cells, which served as a negative control (Erbar et
al., 2008). At 16 h post-infection, the primary human umbilical cord
vein endothelial cells (HUVEC), human lung microvascular endothe-
lial cells (HULEC), and immortalized human endothelial brain cells
(HBEC) were infected with NiV, while the levels of NiV N detected in
the M17 neuronal cells were at least twice the levels found in any of
the endothelial cells used in this assay (Fig. 1). To determine whether
this disparity in NiV N protein expression levels was due to a
difference in the rate of viral replication between cell lines, a single-
step growth curve was performed for human lymphatic lung
microvascular endothelial cells (LYMEC), HUVEC, HULEC, HBEC, and
M17 cells (Fig. 2A). At 16 h post-infection (MOI=1), the viral titer in
M17 cells reached ∼107 TCID50/mL, which indicated a high rate ofFig. 2. Differential susceptibility and growth rate of NiV in endothelial and neuronal
cells. A) Supernatants taken from NiV infected endothelial cells and neuronal cells
(infected at MOI=1) were serially diluted before being used to infect Vero cells to
determine the TCID50/mL at the indicated time points. (* supernatant from M17 was
taken from a 32 h time point) B) The levels of NiV genome were measured from NiV
infected (MOI=1) endothelial and neuronal cell lysates after 5 h of infection to
determine the relative infectibility of infection of each cell type. C) NiV infection of
HUVECs and HULECs (MOI=2). The dotted line delineates the limit of detection (3.1).
Error bars indicate one standard deviation of the mean of 9 replicates for the growth
curve experiments (A and C), and of 3 replicates of the genome copy number
experiment (B).
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by 24 h post-infection; the drop in viral titer at 32 h post-infection
was likely due to both the lack of cells remaining to infect as well as to
viral degradation. In contrast, for the endothelial cells infected with
NiV, the viral titer was barely above the lower limit of detection by
16 h post-infection, though higher titers were detected at 48 h
(Fig. 2A). The delay in viral antigen production and viral titer increase
by the endothelial cells relative to the neuronal cells (Fig. 1) could be
due to differences in the ability of NiV to infect these cell types. In
order to determine potential differences in susceptibility to NiV
infection between the cell types, we extracted total RNA from infected
cells (MOI=1) at 5 h post-infection and used real-time PCR to
determine the relative number of N gene copies present per cell. We
detected high copy numbers of NiV N gene in NiV infected HUVECsFig. 3. NiV infection of endothelial cells induces IFN-β production. A) IFN-β ELISA was pe
endothelial cells at indicated time points. B) Levels of IFN-β mRNA and C) IF-7 mRNA tra
measured by Real-time PCR, which was performed on cDNA generated from extracted total c
the mean of 3 replicates. Labels above the graphs correspond to the data obtained from each
modiﬁcation) A: Relative to levels of IFN-β detected in supernatants from mock-infected c
infected cells at corresponding time point.and M17 neuronal cells (∼1400–1700 copies per cell), and substan-
tially lower copy numbers in HULECs and LYMECs (∼4–5 copies per
cell) (Fig. 2B).
To ensure that a majority of endothelial cells were being infected,
we repeated the growth curve experiment in HUVECs, HULECs, and
LYMECS but increased the MOI to 2. By increasing the input virus,
there was a substantial increase of approximately 1.5 logs in viral titer
in the three endothelial cell types at 16 h post-infection (Fig. 2C).
Nevertheless, the rate of replication still did not reach that of NiV in
M17 cells, which yielded 100-fold higher viral titer at the same time
point (Fig. 2A). Notably, in spite of the signiﬁcant increase in titer at
16 h post-infection in endothelial cell infection provided by increasing
the MOI, there was only a modest (3-fold) difference in titer by 48 h
post-infection between cells infected at a MOI of one versus two.rformed on supernatants taken from NiV infected lung, lymphatic, and umbilical vein
nscription in NiV infected lung, lymphatic, and umbilical vein endothelial cells were
ellular RNA using oligo-dT12–18 primers. Error bars denote one standard deviation from
endothelial cell type. *(Pb0.05); **(Pb0.01) (two-tailed Student's t-test with Welch's
ells at corresponding time point; B and C: Relative to mRNA transcript levels in mock-
Fig. 4. Supernatants from NiV infected endothelial cells contain functional IFN-β. A549
human respiratory epithelial cells were pre-treated with gamma-irradiated super-
natants from mock, UV inactivated NiV, or NiV infected HULECs (panel A), LYMECs
(panel B), or HUVECs (panel C) for 6 h, and then infected with ∼200 PFU/well EMCV for
16–20 h. Cells were stained with crystal violet and absorbance at 600 nm was
measured. Error bars indicate one standard deviation from the mean of 3 replicates.
**(Pb0.01); *(Pb0.05) (two-tailed Student's t-test with Welch's modiﬁcation) Relative
to cells treated with supernatants from mock-infected cells at corresponding time
points.
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LYMECs may be due to lower levels of infectibility (Figs. 2A, C), the
observation that the HUVECs supported NiV replication to a similar
titer as the M17 cells but reached that titer later in infection, (64 h
post-infection) suggests that innate cellular response mechanisms in
endothelial cells may limit early viral replication (Fig. 2C).
NiV infected endothelial cells produce a functional antiviral response
In order to determine the presence or absence of an innate
antiviral response to NiV infection, we performed IFN-β ELISA on
gamma-irradiated supernatants collected from infected cells. While
we conﬁrmed the ability of M17 cells to produce functional IFN-β
(Supplemental Figure 1D), we did not detect an increase in levels of
IFN-β from NiV infected M17 cell supernatants relative to mock-
infected cell controls (data not shown). We detected IFN-β in
supernatants from endothelial cells above baseline levels as early as
16 h post-infection (Fig. 3A, HULEC). The HULECs produced the
highest levels of IFN-β in response to NiV infection. The LYMECs also
generated IFN-β in response to NiV infection with a similar time
course, but produced lower peak levels of IFN-β compared to
HULECs. The HUVECs had a slightly delayed IFN-β response
compared with the HULECs and LYMECs, and also produced 5-fold
lower levels of IFN-β than the other two endothelial cell types
(Fig. 3A). The increases in IFN-β mRNA transcripts of the infected
endothelial cells generally corresponded to the time points in which
increased levels of these proteins in the supernatants were observed
(Fig. 3B). For positive controls, each endothelial cell type was treated
with 50 μg/mL of poly-I:C for 24 h before the supernatant was
harvested to be assayed for IFN-β. The capacity to produce IFN-β
varied according to the particular endothelial cell type. Both the
lung-derived HULECs and LYMECs produced 20–25 IU/mL of IFN-β
when stimulated with poly-I:C, while HUVECs only produced
approximately 4 IU/mL of IFN-β. We observed that the induction
of IFN-β in the infected endothelial cells required viral replication, as
UV inactivated virus failed to induce the endothelial cells to produce
signiﬁcant levels of IFN-β (Fig. 3A). We also measured IRF-7 mRNA
levels at the same time points to determine whether IFN-β signaling
was occurring in infected cells (Fig. 3C). Our results indicated that
IRF-7 mRNA levels in each endothelial cell type were upregulated at
time points which corresponded with those in which IFN-β was
detected in culture supernatants. (Fig. 3C). For HULECs, we found
that at 16 and 24 h post-infection, the IRF-7 mRNA levels were
approximately 10 fold higher than those of mock-infected cells., At
48 h, these levels had increased to 50 fold relative to mock-infected
cell; and then decreased to baseline levels by 64 h. In LYMECs, IRF-7
mRNA was upregulated at 24 h (∼15 fold), only to drop off by 48 h
(Fig. 3C), which may indicate that signaling in LYMECs may be
inhibited at later time points. In HUVECs, IRF-7 mRNA was
upregulated at 48 h, which corresponded to the presence of IFN-β
in culture supernatants at that time point, and see a drop off at 64 h
post-infection. For all 3 endothelial cell types, there was a period of
time following upregulation of IFN-β in which IRF-7 mRNA levels
signiﬁcantly increased, which indicates that at least during those
time points, type-I IFN signaling was not inhibited.
To determine whether the IFN-β produced from NiV infected
endothelial cells was functional, we performed an biologic assay to
measure the ability of the supernatants to protect cells from the
cytopathic effect (CPE) caused by encephalomyocarditis virus
(EMCV). Pre-treatment of A549 human lung airway epithelial cells
with gamma-irradiated supernatants from NiV infected HULECs and
LYMECs at 24, 48, and 64 h provided signiﬁcant protection of the cells
from EMCV-induced CPE, with HULEC supernatants providing some
protection even at 16 h (Figs. 4A and B). Supernatants from NiV
infected LYMECs at 24 h showed 2-fold less protection than the
protection from the corresponding time point from HULEC super-natants. In correlation with the comparatively lower levels of IFN-β
produced by HUVECs, pre-treatment of A549 cells with NiV infected
HUVEC supernatants provided some protection from EMCV CPE, but
the level of protectionwas not as high as that provided by NiV infected
HULEC and LYMEC supernatants (Fig. 4C).
Cell-type speciﬁc subcellular localization of NiV W
We have shown previously that the accessory proteins (NiV C, V,
andW proteins) derived from the NiV P gene have distinct subcellular
localizations in infected Vero cells (Lo et al., 2009). We performed
immunoﬂuorescence assays on the NiV infected neuronal and
endothelial cells to determine whether these proteins localized to
similar compartments as in Vero cells. Interestingly, we found that
while the NiV W localized to the nucleus of M17 cells as it did in Vero
cells, it was primarily found in the cytoplasm of all endothelial cell
types that we infected with NiV (Fig. 5). When expressed from
Fig. 5. Differential subcellular localization of NiV W protein in NiV infected neuronal and endothelial cells. NiV W was detected in infected A) M17 neuronal cells, B) HULEC,
C) LYMEC, and D) HUVEC. Staining for NiV W is in the left-most column using FITC, nuclear staining is in the middle column using DAPI, and a merged image of the two is shown in
the right-most column. Magniﬁcation: 20×.
82 M.K. Lo et al. / Virology 404 (2010) 78–88plasmid DNA, the NiV V and W proteins have antagonistic activities
for IFN-β promoter activation caused by Sendai virus infection. The
nuclear localization of plasmid-expressed NiV W allows it to block
both TLR-3 and virus-induced IFN-β induction pathways (Shaw et al.,
2005). Our ﬁnding that the majority of NiV W protein produced
during infection of endothelial cells is excluded from the nucleus
suggest that TLR-3 mediated induction of IFN-β expression is not
inhibited in endothelial cells as they produce IFN-β during NiV
infection.Fig. 6. NiV infection induces production of inﬂammatory chemokines associated with incr
performed on gamma-irradiated NiV infected HULEC and LYMEC supernatants to detect the p
infected HULEC and LYMEC were measured by real-time PCR, which was performed using cD
monocyte chemotaxis assay. Levels of THP-1 monocytic cell chemotaxis across a 5 μm pore
levels of chemotaxis induced by supernatants from poly-I:C stimulated endothelial cells. La
Error bars indicate one standard deviation of the mean of 3 replicates. **(Pb0.01), *(Pb0.05
levels in mock treated supernatants at corresponding time point; B, D: Compared to levels o
to levels of chemotaxis induced by mock treated endothelial cell supernatants at corresponNiV infection induces production of inﬂammatory chemokines and
promotes monocyte and T-lymphocyte chemotaxis
One of the main pathological ﬁndings from humans infected with
NiV is vasculitis characterized by focal and transmural mixed
inﬂammatory inﬁltrates consisting of neutrophils, macrophages,
lymphocytes, and microglia (Wong et al., 2002). Since endothelial
cells are one of the primary targets of NiV infection, we wanted to
determine whether endothelial cells could serve as a source ofeased monocyte chemotaxis in endothelial cells. A and C) Luminex bead assays were
resence of IL-8 andMCP-1. B and D) Levels of IL-8 andMCP-1mRNA transcription in NiV
NA generated from extracted total cellular RNA using oligo-dT12–18 primers. (E) THP-1
membrane induced after 2 h of exposure to above mentioned supernatants relative to
bels above the graphs correspond to the data obtained from each endothelial cell type.
). (two-tailed Student's t-test with Welch's modiﬁcation) A, C: Compared to chemokine
f mRNA frommock-infected endothelial cells at corresponding time point; E: Compared
ding time point.
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Fig. 7. NiV infection induces production of inﬂammatory cytokines associated with increased T-lymphocyte chemotaxis in endothelial cells. A) Luminex bead assays were performed
on gamma-irradiated NiV infected HULEC and LYMEC supernatants to detect the presence of IP-10 (CXCL10). B) Levels of IP-10mRNA transcription in NiV infected HULEC and LYMEC
were measured by real-time PCR, which was performed using cDNA generated from extracted total cellular RNA using oligo-dT12–18 primers. C) Levels of JE-6.1 T-lymphocyte
chemotaxis across a 5 μm pore membrane induced after 2 h of exposure to NiV infected HULEC and LYMEC supernatants relative to supernatants from poly-I:C stimulated
endothelial cells. Labels above the graphs correspond to the data obtained from each endothelial cell type. Error bars indicate one standard deviation of the mean of 3 replicates.
**(Pb0.01), *(Pb0.05). (two-tailed Student's t-testwithWelch'smodiﬁcation) A: Compared tomock-infected endothelial cell supernatants at corresponding time point; B: Compared
to mock-infected endothelial cell mRNA transcript levels at corresponding time point; C: Compared to chemotaxis induced by mock supernatants at corresponding time point.
84 M.K. Lo et al. / Virology 404 (2010) 78–88inﬂammatory cytokines and chemokines that would contribute to the
manifestation of vasculitis seen in human disease. Luminex multiplex
bead array assays were performed to detect the presence of
inﬂammatory cytokines and chemokines in NiV infected HULEC and
LYMEC supernatants. In spite of a gradual increase in levels of MCP-1
and IL-8 in mock treated endothelial cell supernatants due to
accumulated basal levels of expression of both chemokines over
time, we detected signiﬁcant increases above baseline levels of IL-8,
MCP-1, IP-10, and IL-6 (IL-6 upregulation only in HULECs — data not
shown) consistently by 48 h post-infection (Figs. 6A, C; Fig. 7A). We
did not ﬁnd signiﬁcant increases in these chemokines in HUVEC or
M17 cell supernatants (data not shown). We demonstrated that viralreplicationwas required in order to induce upregulated levels of these
chemokines, as UV inactivated virus stocks did not signiﬁcantly
increase levels of these chemokines at any of the corresponding time
points in which we harvested supernatants (Figs. 6A, C; Fig. 7A). The
substantial increases (from 4 fold to 60-fold) we observed in mRNA
transcription of these genes over baseline levels generally corre-
sponded to the time points in which increased levels of these proteins
in the supernatants was observed (Figs. 6B, D; Fig. 7B). In order to
determine any functional signiﬁcance correlated with these upregu-
lated chemokines, we performed chemotaxis assays using the THP-1
monocyte and the JE-6.1 T-lymphocyte cell lines. We observed that
the supernatants taken from NiV infected HULEC and LYMECs at 48
85M.K. Lo et al. / Virology 404 (2010) 78–88and 64 h post-infection induced a signiﬁcant increase in both
monocyte and lymphocyte chemotaxis over mock supernatants
(Figs. 6E, 7C). Supernatants taken from poly-I:C stimulated endothe-
lial cells consistently induced high levels of chemotaxis, and were
used as the positive control representing maximum induction of
chemotaxis.
Discussion
This is the ﬁrst report characterizing the innate antiviral responses
of human primary endothelial cells against NiV infection. Despite
previous reports of the ability of NiV V and W proteins to block IFN-β
production via TLR-3 and mda-5 mediated signaling (Parisien et al.,
2009; Shaw et al., 2005), we have shown that NiV infected primary
human endothelial cells can generate a functional IFN-β response.
Surprisingly, we found that the majority of NiVW protein detected by
immunoﬂuorescence assays of NiV infected endothelial cells localized
to the cytoplasm, contrary to the nuclear localization in infected M17
neuronal cells as shown in this study, and in infected Vero and
plasmid transfected HeLa cells as shown in prior studies (Lo et al.,
2009; Shaw et al., 2005). Since nuclear localization of plasmid-
expressed NiV W was required to block TLR-3 signaling by over
expression of TRIF, it is possible that TLR-3 signaling is the means by
which primary endothelial cells generate the observed IFN-β response
to NiV infection. Another possibility regarding the source of IFN-β
production is via the RIG-I RNA helicase pathway. RIG-I is responsible
for inducing cytokine responses to the stem loop structured leader of
measles virus, as well as to Sendai virus infection (Melchjorsen et al.,
2005; Plumet et al., 2007; Shingai et al., 2007). Parainﬂuenza simian
virus 5 (PIV5) has a genomic promoter sequence that limits detection
by RIG-I (Manuse and Parks, 2009). While many paramyxovirus V
proteins, including that of NiV, bind and inhibit the antiviral signaling
activity of mda-5, they have not had the same effect on RIG-I (Childs et
al., 2007, 2009; Parisien et al., 2009). It is possible that in spite of the
ability of NiV infected endothelial cells to mount an IFN-β response as
early as 16 h post-infection, NiV is able to overcome the effects of IFN-
β signaling, because we detected a continual increase in virus titer in
the presence of IFN-β production (Figs. 2 and 3). We did not detect
any evidence of IFN-β expression at earlier time points of endothelial
cell infection (2, 5, and 8 h) (Supplemental Figures 1A–C, 2). Given the
ability of the NiV V andW proteins to inhibit the induction of IFN-β, a
reverse genetic approach would be warranted to study the potential
actions of these proteins at early time points (Childs et al., 2007; Shaw
et al., 2005). While we have measured IRF7 mRNA levels in this study
(Fig. 3C), it is worth investigating the cellular localization of
phosphorylated/unphosphorylated Interferon Regulatory Factors 3
and 7 (IRF-3 and IRF-7) in endothelial cells to evaluate additional
mechanisms that provide avenues for type-I IFN production. The
results obtained from the immunoﬂuorescence assays of NiV W
protein in this study highlight the beneﬁts of utilizing primary
endothelial cells in attempting to study the pathogenesis of NiV
infection, as they signiﬁcantly differ from infections performed in both
IFN-incompetent and competent cell lines (Vero, Vero E6, 293T)
(Ciancanelli et al., 2009; Emeny and Morgan, 1979; Lo et al., 2009).
While the macroscopic pathological features of NiV infection in
humans have been well described (Wong et al., 2002), the molecular
mechanisms underlying the pathogenesis of NiV infection remain
largely undeﬁned. Given the pronounced vasculitis observed in the
CNS and lungs of human cases, we hypothesized that measuring
the presence of inﬂammatory chemokines secreted by primary targets
of NiV infection would identify possible mechanisms by which
the observed vasculitis is induced. Chemokines play a major role in
guiding the migration of cells, and are a diverse family of low
molecular weight proteins that are divided into 4 subfamilies based
on structure and function. Twomajor subfamilies include the CXC and
CC chemokines. CXC chemokines are split into two types, those thatcontain a glutamate-leucine-arginine (ELR) motif, and those that do
not (non-ELR). CXC chemokines that have the ELR motif (i.e., IL-8/
CXCL8) primarily attract neutrophils and are associated with bacterial
infections, but have limited effects on T cells and monocytes. Non-ELR
CXC chemokines (i.e., IP-10/CXCL10) tend to attract activated T cells
and NK cells, and are typically associated with antiviral activities
(Mahalingam et al., 1999). On the other hand, CC chemokines (i.e.,
MCP-1/CCL2) attract T cells, monocytes, and macrophages, but not
neutrophils (Lane et al., 2006). We have shown that NiV infection of
human lung and lung lymphatic endothelial cells results in the
upregulation of inﬂammatory chemokines MCP-1, IL-8, and IP-10
which may contribute to the induction of both monocyte and T-
lymphocyte chemotaxis. In clinical settings, epyema and parapneu-
monic effusions are associated with upregulated levels of MCP-1 and
IL-8 that functionally induce chemotaxis (Antony et al., 1993). A cDNA
array study of respiratory syncytial virus (RSV) infection of human
airway epithelial cells indicated an increase in IL-8 and MCP-1, which
correlates with observed peribronchial mononuclear inﬁltrate, with
eosinophilic and basophilic degranulation in human infections (Zhang
et al., 2001). Alveolar hemorrhage, pulmonary edema, and aspiration
pneumonia were seen in the initial NiV outbreak, as well as in
subsequent Bangladesh outbreaks, in which an increase in the rate of
severe respiratory distress was reported (Goh et al., 2000; Hossain et
al., 2008; Lee et al., 1999; Paton et al., 1999; Wong et al., 2002).
Importantly, MCP-1, IL-8, and IP-10 are upregulated in both
experimental infectious and non-infectious CNS pathology in
monkeys, mice and rats (Glabinski and Ransohoff, 1999). All three
chemokines play a role in lymphocyte trafﬁcking in CNS diseases
(Klein, 2004; Loetscher et al., 1994; Pace et al., 1999; Penido et al.,
2003). MCP-1 also regulates permeability of the blood–brain–barrier
through altering the arrangement of endothelial tight junction
proteins (Stamatovic et al., 2005). Clinical studies of patients infected
with Japanese encephalitis virus showed that infection is correlated
with elevated levels of IL-8 in the cerebrospinal ﬂuid (CSF) (Singh et
al., 2000). Studies of West Nile virus infection in the mouse model
indicate that IP-10 is induced in neurons and promotes T-cell
trafﬁcking (Klein et al., 2005; Zhang et al., 2008). CXCR3, the receptor
for IP-10, is one of several prominent chemokine receptors expressed
in the CNS at various stages of mouse hepatitis virus (MHV)-induced
encephalomyelitis (Lane et al., 2006). NDV induces the mouse
homolog of IP-10 (Crg-2) in glial cells and astrocytes, while measles
virus induces IP-10 in glioblastoma cells (Cheng et al., 1998; Fisher et
al., 1995; Nazar et al., 1997; Vanguri and Farber, 1994). Since IP-10 by
its name (interferon induced inﬂammatory protein) is widely known
to be induced by IFN-γ, our detection of increased levels of IP-10 in
NiV infected endothelial cells was somewhat unexpected, as IFN-γ is
primarily produced by activated T cells. However, there are other
signaling pathways that do not require IFN-γwhich can contribute to
IP-10 expression. The HIV Tat induces IP-10 via the p38 MAP kinase
pathway and to induce IL-8 and MCP-1 via the ERK1/2 pathway
(Kutsch et al., 2000). The MAP kinase and ERK1/2 pathways have not
yet been examined as potential players in the pathogenesis of NiV
infection. The ﬁnding that RIG-I mediated induction of IFN-β and
activation of dendritic cells requires an intact p38 MAP kinase
pathway emphasizes the need for the investigation of these respective
signaling pathways (Mikkelsen et al., 2009). Another important if not
overlooked area of study is the impact of NiV induced chemokines on
the action of matrix metalloproteinases in the CNS (Khuth et al., 2001;
Owens et al., 2005). It is notable that even though we have correlated
upregulated inﬂammatory chemokine levels with increased mono-
cyte and T-lymphocyte chemotaxis, incubating NiV infected super-
natants with antibodies against IL-8 and MCP-1 simultaneously and
against IP-10 individually did not ablate the increased levels of
chemotaxis (data not shown). This indicates that there are other
inﬂammatory chemokines involved that were not addressed in this
study. Future studies will focus on identiﬁcation of speciﬁc
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lymphocyte chemotaxis.
In summary, we have characterized the replication rates of NiV
infection in neuronal and endothelial cells, detected antiviral
responses which correlated with an unexpected cytoplasmic subcel-
lular localization of the NiV W protein, and have characterized the
innate inﬂammatory response of endothelial cells to NiV infection.
Our ﬁndings suggest that the induction of pro-inﬂammatory chemo-
kines in NiV infected primary endothelial cells in vitro is consistent
with the observed prominent vasculitis seen in human cases of NiV
infection, and these results provide initial molecular insights into the
pathogenesis of NiV in humans.
Materials and methods
Cells and viruses
Primary human umbilical cord vein endothelial cells (HUVEC),
human lymphatic lung microvascular endothelial cells (LYMEC), and
human lung microvascular endothelial cells (HULEC) were obtained
from Lonza. HUVECs were maintained according to the manufac-
turer's instructions in endothelial basal media (EBM) supplemented
with aliquots of bovine brain extract with heparin, human epidermal
growth factor, hydrocortisone, fetal bovine serum (FBS) (up to 2%
ﬁnal volume) and antibiotics Amphotericin B and Gentamicin, all of
which were supplied by Lonza. LYMECs and HULECs were maintained
in EBM-2 (Lonza) supplemented with aliquots of human epidermal
growth factor, vascular endothelial growth factor, ﬁbroblast growth
factor, insulin-like growth factor, FBS (up to 5% ﬁnal volume),
hydrocortisone, and antibiotics Amphotericin B and Gentamicin all
provided by Lonza. Endothelial cells obtained from Lonza were used
within the ﬁrst 5 passages, and were cultured in ﬂasks pre-treated
with 0.1% gelatin (Sigma). An immortalized human brain endothelial
cell line (HBEC) was obtained from the Cell Culture Development
Team at CDC, and was used within passage numbers 8–15. HBECs and
EA926.hy cells (hybrid fusion of HUVEC and A549 cells) (ATCC) were
maintained in M199 medium supplemented with 15% fetal bovine
serum (FBS) (GIBCO-BRL Life Technologies, Inc., Frederick, MD), 16 U/
mL heparin (ESI Pharmaceuticals, Cherry Hill, NJ), 25 mM HEPES
buffer, 2 mM L-glutamine, 100 U/mL penicillin, and 100 U/mL
streptomycin. BE(2)-M17 human neuroblastoma cells (M17) were
obtained from ATCC and maintained in OPTI-MEM supplemented
with 5% FBS. THP-1 monocytic leukemia cells and Jurkat JE-6.1 cells
(ATCC TB-152) were maintained in RPMI 1640 with 10% FBS, 100 U/
mL penicillin and 100 U/mL streptomycin. Vero and A549 cells were
maintained in DMEM with 10% FBS, 100 U/mL penicillin and 100 U/
mL streptomycin. All cell lines were cultured at 37 °C with 5% CO2. All
work with live NiV was performed under biosafety level 4 conditions
in the Maximum Containment Laboratory (MCL) at the Centers for
Disease Control and Prevention or at the Australian Animal Health
Laboratory (AAHL). The NiV stock used in these experiments were
from an isolate from the Malaysian outbreak in 1999 (Chua et al.,
2000), passed four times on Vero E6 cells. Any potentially infectious
material removed from the MCL was either sterilized with 5×106 rad
in a Cobalt-60 gamma cell irradiator or chemically denatured with
TRIZOL reagent (Invitrogen). Encephalomyocarditis virus (EMCV) was
propagated in HeLa cells and had a titer of ∼4.95×105 TCID50/mL.
NiV immunolabeling assay
Assays were performed as previously described (Aljofan et al.,
2008). Brieﬂy, 96-well white plates of NiV infected endothelial and
neuronal cells ﬁxed with 100% cold methanol 16 h post-infection
were washed 3 times with Phosphate Buffered Saline containing
0.05% Tween-20 (PBS-T). Plates then were protein blocked with
100 mL of 2% skim milk in PBS-T and incubated at 37 °C for 30 min.After protein blocking, plates were washed 3 times with PBS-T,
followed by incubation with 100 μL anti-NiV antibody (prepared by
AAHL's Bioreagents Development Group) diluted 1:1000 in PBS-T
containing 2% skim milk for 30 min at 37 °C and then washed 3 times
with PBS-T. Plates were incubated with 1% H2O2 (Sigma) for 15 min at
room temperature then washed with PBS-T 3 times. Anti-rabbit HRP
conjugated antibody 100 μL (Sigma) diluted 1:2000 in PBS-T contain-
ing 2% skim milk, were added to each well and plates incubated at
37 °C for 30 min. Plates were washed 3 times with PBS-T and 100 μL
aliquots of Chemiluminescent Peroxidase Substrate-3 (CPS-3, Sigma)
diluted 1:10 in Chemiluminescent assay buffer (20 mM Tris–HCl,
1 mMMgCl2, pH 9.6) were added to all wells. Plates were incubated at
room temperature for approximately 15 min, and then read using a
Luminoskan Ascent luminometer (Thermo) using 100 ms integration
per well.
Immunoﬂuorescence assay
∼5×103 neuronal or endothelial cells were seeded onto 8-
chamber glass slides pre-treated with 0.1% gelatin (for endothelial
cells), and infected with NiV at multiplicity of infection (MOI) of 0.1
(for M17) to 1 (endothelial cells). After 16–48 h, slides were ﬁxed
with cold methanol for 15 min, and upon removal of the methanol,
were allowed to dry at room temperature before either being stored at
−20 °C or blocked with blocking buffer (PBS, 0.1% Triton X-100, 10%
goat serum) for 5–10 min. Primary antibodies generated against NiV
W (Lo et al., 2009) was diluted in blocking buffer at a dilution of 1:500,
then added to the chamber slides which were incubated at room
temperature for 45 min. After 3 washes with blocking buffer, slides
were incubated with a secondary goat anti-mouse antibody conju-
gated with FITC diluted 1:1000 in blocking buffer, along with a 1:1000
dilution of DAPI to stain the nuclei. Slides were viewed on an
AxioScope microscope, and AxioVision version 4.7 was used to
capture images (Zeiss).
One-step growth curve/median tissue culture infectious dose
(TCID50 ) analysis
Brieﬂy, 5×104 to 4.5×105 cells were seeded on 6-well plates and
infected for 1 h at a multiplicity of infection (MOI) of 1 or 2. Inoculum
was removed and replaced with 2 mL of fresh media per well.
Supernatants of infected cells were collected at 2, 5, 8, 16, 24, 48, and
64 h post-infection and were serially diluted ten-fold to infect ∼3–
4×104 Vero cells in a 96-well plate to determine the TCID50/mL,
which was calculated using the Spearman–Kärber method (Kärber,
1931). To generate IFN-β control supernatants, endothelial cells were
treated with 50 mg/mL of polyinosinic:polycytidylic acid (poly-I:C)
for 24 h before the supernatants were harvested and gamma-
irradiated as mentioned above.
Luminex® multiplex cytokine bead assay
100 μL of gamma-irradiated supernatant per sample was subjected
to a Luminex multiplex cytokine bead assay according to manufac-
turer's protocols (Invitrogen). Brieﬂy, supernatants were incubated
for 2 h in a 96-well ﬁlter plate with a mixture of beads conjugated
with antibodies speciﬁc for Interleukin 6 (IL-6), (IL-8/CXCL8), IL-1β,
inﬂammatory protein 10 (IP-10/CXCL 10), and monocyte chemoat-
tractant protein 1 (MCP-1/CCL2). After two washes, the beads were
incubated for 1 h with biotinylated detector antibodies speciﬁc for
different epitopes of aforementioned cytokines and chemokines. After
another two washes, the beads were incubated with streptavidin
conjugated with phycoerythrin (PE) for 30 min. After 3 washes, the
beads were resuspended in 100 μL of wash buffer, and the
ﬂuorescence signal of the PE was read in the xMap® System using a
Luminex® 100 IS cytometer (Bio-Rad). Levels of cytokines present in
87M.K. Lo et al. / Virology 404 (2010) 78–88the samples were measured using cytokine standards provided with
the bead kits (Invitrogen).
RNA extraction, reverse transcription, and real-time PCR
Total RNA were extracted from infected cell lysates using TRIZOL
reagent (Invitrogen). 0.5 to 1 μg of RNA from each sample was treated
with DNase I (Invitrogen), and subject to reverse transcription with
oligo-dT12–18 primers (Invitrogen) using Superscript III reverse
transcriptase (Invitrogen). The resulting cDNA was diluted 1 in 5,
from which 2 μL of cDNA was used in a 25 μL real-time PCR reaction
using cytokine gene-speciﬁc primers with the Jumpstart SYBR Green
kit (Sigma) on an ABI 7900HT PRISM sequence detection system
(Applied Biosystems). Primer sequences of speciﬁc cytokine genes are
available upon request. To determine the number of NiV N gene copies
present in infected cell lysates (5 h post-infection), RNA extraction
and reverse transcription was performed as stated above with a
primer which anneals to the 3′ end of the genome. Ensuing real-time
PCR was performed as above using primers targeting the NiV N gene.
NiV N gene copy numbers were calculated using a standard curve
generated by 10-fold dilutions of a predetermined copy number of
synthetic NiV N gene RNA.
Interferon bioassay
Assays were performed as described previously with some
modiﬁcations (Green et al., 1980). Brieﬂy, 3.5×104 A549 cells per
well were plated in 96-well microtiter plates. Cells were treated for
6 h with either interferon beta (IFN-β) (Invitrogen), or 100 μL of
gamma-irradiated supernatants from cells infected with NiV. Super-
natants were removed, and each well was infected with ∼200 PFU of
Encephalomyocarditis virus (EMCV) for 16–20 h in DMEM supple-
mented with 10% FBS. The supernatants were then removed, and the
cells were stained with crystal violet solution for 5 min, washed once
with PBS, and were scored for cytopathic effect (CPE) using a TECAN
Sunrise plate reader at an absorbance of 600 nm. Uninfected cells
stainedwith crystal violet served as a negative control for levels of CPE
and was scored as having 100% protection from EMCV-induced CPE.
Interferon-β ELISA
Assays were performed according to manufacturer's protocols
using a one-step sandwich human IFN-β ELISA kit (Invitrogen).
Brieﬂy, 100 μL of gamma-irradiated supernatants from NiV infected
cells were added to each well of a 96-well microplate pre-coated with
afﬁnity-puriﬁed polyclonal antibody to human IFN-β, along with
50 μL of horseradish peroxidase labeled-antibody for 2 h on a plate
shaker. After 3 washes, 100 μL of color developing solution was added
to each well and incubated at room temperature for 30 min, upon
which 100 μL of reaction stopper solution was added to each well. The
absorbance of the reaction mixture in each well was read at 450 nm,
with the reference wavelength set to 630 nm.
Chemotaxis assay
Assays were performed according to manufacturer's instructions
using the Chemicon QCM™ 5 μm 96-well cell migration kit (Milli-
pore). In brief, THP-1 or JE-6.1 cells were centrifuged (1500 RPM,
5 min), resuspended to a cell count of ∼1.5×106/mL, and starved in
DMEM without serum or chemoattractants for ∼2 h before being
resuspended in fresh media and dispensed into the migration
chamber at 1.2–1.5×105/well. Wells of a 96-well feeder tray were
ﬁlled with 150 μL of either fresh endothelial growth media, or
gamma-irradiated supernatants from NiV infected cells. After a 2 h
incubation of the chambers in the feeder wells, transmigrated cells in
the feeder wells were transferred to a 96-well plate, whiletransmigrated cells attached to the outer surface of the incubation
chamber were washed into a new feeder plate. These detached cells
were then combinedwith the transmigrated cells in the 96-well plate,
which were lysed with a lysis buffer mixed with CyQuant GR Dye,
which is a DNA-binding ﬂuorescent dye. The cell lysates were then
transferred to white microtiter plates (Thermo) and read with a
Fluoroskan Ascent ﬂuorescence plate reader using the 480/520 nm
ﬁlter set (Thermo) with an integration time of 120 ms. Fluorescence
levels of the DNA-binding dye present in the cell lysates were
indicative of the relative number of cells that migrated through the
chamber. Supernatants taken from poly-I:C stimulated endothelial
cells served as positive controls for maximum induction of trans-
membrane migration of THP-1 cells.
Statistical methods
The immunolabeling assay, IFN-β ELISA, EMCV CPE assay,
quantitative cytokine and chemokine mRNA and protein expression
proﬁles, and chemotaxis assays were compared using two-tailed
Student's t-tests with Welch's modiﬁcation. Differences were consid-
ered signiﬁcant at Pb0.05.
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